ライフサイエンスコーパス: -grade

1 oducts, chemical waste dumps, and analytical-grade material, covering the production time period from

2 ts, 71% (95% CI, 67% to 75%) experienced any-grade treatment-related AEs (most commonly fatigue [25%]

3 breast and ovarian lesions using a clinical-grade contrast agent (kinase insert domain receptor [KDR

4 therapy of low-dose anti-CD3 with a clinical-grade self-containing L. lactis, appropriate for human a

5 sing, the cost for biomanufacturing clinical-grade patient specific iPSCs and their derivatives are v

6 Enhancements in clinical-grade next-generation sequencing (NGS) have fueled the a

7 ort on the feasibility of producing clinical-grade BCR-ABL-specific cytotoxic T lymphocytes (CTLs), e

8 42 patients with CUP using targeted clinical-grade, next-generation sequencing of circulating tumor D

9 ed the therapeutic potential of the clinical-grade alkyl-phospholipid ether analog CLR1404, 18-(p-iod

10 geted ultrasonography (US) by using clinical-grade vascular endothelial growth factor receptor 2 (VEG

11 nostatic cycling when paired with commercial-grade cathodes.

12 be carried out on multigram scales in common-grade solvents without the need for reaction mixtures to

13 realized through the use of compositionally-graded alloy libraries, which were photo-thermally heate

14 This platform is produced with a consumer-grade 3D-printer, using fused deposition modeling.

15 eliberation, the ECDP writing committee down-graded recommendations regarding bile acid sequestrant u

16 versatile tool for generating sandwich ELISA-grade and bispecific reagents.

17 mbrane proteins as an inspiration for a food-grade alternative process.

18 g chlorogenic and rosmarinic acids, and food-grade phenolic apple and rosemary extracts at various do

19 ient sources of well defined, low cost, food-grade maltooligosaccharides (MOS).

20 he resulting fractions yielded isolated food-grade MOS ranging in DP from 3 to 7.

21 Novel food-grade hybrid encapsulation structures based on the entra

22 t from dental pockets was achieved with food-grade cuttlefish ink as a contrast medium.

23 High-grade B-cell lymphomas (HGBLs) with MYC and BCL2 and/or

24 High-grade DLBCL and MCL, as well as MF, are frequently secon

25 High-grade glioma (HGG) is a group of primary malignant brain

26 High-grade gliomas (HGGs) include the most common and the mos

27 High-grade serous (HGS) ovarian cancer accounts for 90% of al

28 High-grade serous ovarian cancer (HGSC) is an aggressive canc

29 High-grade serous ovarian cancer is the most common ovarian c

30 High-grade serous ovarian carcinoma (HGSOC) is the most frequ

31 High-grade tumors relapsed more frequently early during follo

32 High-grade tumors require multidisciplinary treatment consist

33 HO IV: 13, without biopsy low-grade: 1, high-grade: 1) were investigated with a hybrid PET/MR scanner

34 In matched samples from 11 high-grade serous ovarian cancer patients, we detected 2-20-f

35 s were extracted from 40 tumor VOIs (26 high-grade), 36 BPH VOIs, 6 prostatitis VOIs, and 37 healthy-

36 lity colonoscopy, proximal polyps, or a high-grade or large adenoma (>/=20 mm) at baseline (8865 [74%

37 s infection, cytological abnormalities, high-grade lesions, and cervical procedures related to HPV 31

38 roteins differentially expressed across high-grade glioma TMEs.

39 The adult high-grade B-cell lymphomas sharing molecular features with B

40 In those tested, virtually all high-grade disease occurred in the 43.1% of women who were HP

41 cted women have a higher burden of anal high-grade squamous intraepithelial lesions (HSIL) and anal c

42 -grade [moderately differentiated], and high-grade [poorly differentiated], respectively), chromogran

43 g (31 mutations per sample +/- 15), and high-grade cancer (33 mutations per sample +/- 18) (P = .30).

44 ncement (CE) suggested its absence, and high-grade CE, the presence of neovascularization.

45 uded low-grade CIN (grade 1 [CIN1]) and high-grade CIN (grade 2 [CIN2] and grade 3 [CIN3]).

46 r differentiating between low-grade and high-grade DCIS.

47 ry of pancreatic cancer (P = 0.027) and high-grade dysplasia (HGD) (P = 0.003) were independent risk

48 mon diagnoses were meningioma (37%) and high-grade glioma (20%).

49 clear differentiation between low- and high-grade glioma (area under the receiver operating characte

50 boost" trial showed that young age and high-grade invasive carcinoma were the most important risk fa

51 ransformed and neoplastic low-grade and high-grade prostate epithelial tissue from radical prostatect

52 PH, prostatitis, or healthy tissue) and high-grade tumors from other tissue (low-grade tumors or beni

53 rfusion and metabolism between low- and high-grade tumors in the transgenic adenocarcinoma of mouse p

54 Tumor VOIs were marked as high-grade (>/=Gleason grade group 3) or not.

55 Malignant disease was defined as high-grade dysplasia or invasive adenocarcinoma on results of

56 cases of high-risk (hr) HPV-associated high-grade lesions and carcinomas in the anogenital region an

57 observed in patients with asymptomatic high-grade carotid disease versus patients with acutely sympt

58 rson-years among patients with baseline high-grade dysplasia (95% CI 4.2-12.5).

59 rson-years among patients with baseline high-grade dysplasia (95% CI 8.8-20.7).

60 timal rCBV ratio to distinguish between high-grade and low-grade glial tumors.

61 imal rCBV ratio to discriminate between high-grade and low-grade tumors to be 2.21.

62 resistance in ovarian and other cancers.High-grade serous ovarian cancers (HGS-OvCa) frequently devel

63 er in comparison with breast carcinoma, high-grade and basal-like tumors respectively.

64 e distal fallopian tube among all cases.High-grade serous carcinomas (HGSCs) are associated with prec

65 n 93.4% of cases, and dedifferentiated (high-grade cancer) in 41.7% of cases at prevalence screening

66 m >/= 3 + 4, whereas TBRs discriminated high-grade disease from normal lobes better.

67 bits the progression of KrasG12V-driven high-grade glioma.

68 p comprised 27 non-dysplastic and eight high-grade dysplasia cases, whereas the high-risk group (8% o

69 spectively), and patients who had fewer high-grade tumors (13% v 64%, respectively) or right-sided pr

70 s 34.9% (22 of 63); the sensitivity for high-grade DCIS components was 91.8% (45 of 49) versus 36.7%

71 for moderate-grade disease, and 17% for high-grade disease; the corresponding risks of any recurrence

72 r LGD, and 0.43 (95% CI, 0.36-0.46) for high-grade dysplasia.

73 s one of the progenitor populations for high-grade serous ovarian cancer (HGSC).

74 formed meta-analysis on the results for high-grade serous ovarian cancer with the results from analys

75 he lack of effective chemotherapies for high-grade serous ovarian cancers (HGS-OvCa) has motivated a

76 ealth Organization [WHO] grade II) from high-grade glioma (HGG) (WHO grade III or IV).

77 criminating normal and hyperplasia from high-grade lesions (AUC > 0.94).

78 inally, liver cancer organoid-generated high-grade tumors exhibited significantly increased extracell

79 ith age-adjusted IPI 2,3) of the German High-Grade Non-Hodgkin Lymphoma Study Group were analyzed wit

80 these, 376 had no dysplasia and 22 had high-grade dysplasia or intramucosal adenocarcinoma.

81 nts), 51 were non-dysplastic and 14 had high-grade dysplasia.

82 riminate HPV16-positive women that have high-grade disease or worse.

83 ays a crucial role in cancers that have high-grade histology.

84 I 96-100) and the probability of having high-grade dysplasia or intramucosal adenocarcinoma was 0% (0

85 -27), whereas the probability of having high-grade dysplasia or intramucosal adenocarcinoma was 87% (

86 oderate risk; the probability of having high-grade dysplasia was 14% (9-21).

87 ostate stem-cell antigen could identify high-grade dysplasia/cancer with an accuracy of 96% (95% CI,

88 llicular lymphoma, and MYC/BCL2/BCL6 in high-grade B-cell lymphomas are essential for diagnosis.

89 n (mTOR) is prominently dysregulated in high-grade glial brain tumors, blockade of PI3K or AKT minima

90 ow-grade glioma (AUC, 0.818) and MTI in high-grade glioma (AUC, 0.854) and for all WHO grades (AUC, 0

91 ct somatic retrotransposition events in high-grade ovarian serous carcinoma.

92 pharmacologic suppression of MARCKS in high-grade RCC cell lines in vitro led to a decrease in cell

93 no approved biomarkers for olaparib in high-grade serous ovarian cancer (HGSOC).

94 In high-grade serous ovarian cancer (OV), the bulk of genetic ch

95 (beta) (CaMKK2) is highly expressed in high-grade serous ovarian cancer, and we investigated its rol

96 h the development of drug resistance in high-grade serous ovarian cancer, were examined from patient

97 prBP protein levels were upregulated in high-grade serous ovarian patient tumors, where the FoxM1 sig

98 a significant reduction in perfusion in high-grade tumors that associated with increased hypoxia and

99 and macrophages (GAM), which infiltrate high-grade gilomas, constitute a major cellular component of

100 efficacy, its primary adverse effect is high-grade thrombocytopenia.

101 efore classified as WHO grade III or IV high-grade gliomas (HGGs).

102 en loss, with early neoplastic lesions (high-grade prostatic intraepithelial neoplasia) with striking

103 Many high-grade serous carcinomas (HGSCs) of the pelvis are though

104 Despite multimodality treatment, most high-grade gliomas eventually recur and are ultimately incura

105 tumor specimens of 213 patients (mostly high-grade gliomas [89%]) included in the Vienna Cancer and T

106 tients with a clinical diagnosis of non-high-grade DCIS that would preclude active surveillance.

107 nical trials randomizing women with non-high-grade DCIS to active surveillance, defined as imaging su

108 ificant proportion of patients with non-high-grade DCIS will harbor invasive carcinoma.

109 enting with a clinical diagnosis of non-high-grade DCIS, 8320 (22.2%) had invasive carcinoma based on

110 Medulloblastomas (MBs), but not high-grade gliomas (HGGs), demonstrated spatially homogeneous

111 HR, 1.14; 95% CI, 1.01 to 1.29) but not high-grade prostate cancer (HR, 0.83; 95% CI, 0.64 to 1.07).

112 The primary outcomes were incidence of high-grade cervical disease (cervical intraepithelial neoplas

113 e is known about the long-term yield of high-grade cervical intraepithelial neoplasia (CIN) and the i

114 rvical screening increases detection of high-grade cervical intraepithelial neoplastic lesions and in

115 r-protocol population, the incidence of high-grade cervical, vulvar and vaginal disease related to HP

116 te persistently high detection rates of high-grade DCIS in two consecutive subsequent screening round

117 Conversely, the detection rate of high-grade DCIS remained at the high level found in the preva

118 methylation can predict the presence of high-grade disease at histology in women testing positive for

119 is associated with later development of high-grade dysplasia (HGD) or colorectal cancer.

120 er, little is known about their risk of high-grade dysplasia (HGD) or esophageal adenocarcinoma (EAC)

121 e detected at the pre-invasive stage of high-grade dysplasia with the novel Cytosponge device.

122 E, 22 samples of LGD, and 34 samples of high-grade dysplasia) were identified, randomly assigned to 7

123 e expression data derived from a set of high-grade human gliomas, shows that high Caspase-8 expressio

124 The association of high-grade invasive tumor with IBTR diminished during follow-

125 th significantly increased detection of high-grade precancerous cervical lesions compared to cytology

126 Of high-grade sarcomas, OSs are among the most curable, with mor

127 been recognized as a site of origin of high-grade serous ovarian cancer (HGSC).

128 BB is repressed in approximately 30% of high-grade serous ovarian cancer (HGSOC) patients and is a re

129 ted tomography (CT) imaging features of high-grade serous ovarian cancer (HGSOC), to assess their ass

130 A key feature of high-grade serous ovarian carcinoma (HGSOC) is frequent ampli

131 se progression [DP], 13%) versus 33% of high-grade tumors (grade 3 or 4) (complete response, 0%; part

132 the presence of unstable bradycardia or high-grade arteriovenous block in the absence of myocardial d

133 the presence of unstable bradycardia or high-grade arteriovenous block without significant alteration

134 Adenocarcinoma or high-grade dysplasia is present in 14.9% of resected pancreat

135 ctors for malignancy (adenocarcinoma or high-grade dysplasia) occurring in the setting of an MCN.

136 f premalignant lesions, such as low- or high-grade dysplastic nodules (LGDNs and HGDNs, respectively)

137 or important proportions of low- and/or high-grade lesions, but their contribution dropped in ICCs, w

138 Ovarian high-grade serous carcinoma (HGSC) results in the highest mor

139 ignificantly increased risk for ovarian high-grade serous carcinoma (HGSC; 3.8% cases vs. 0.2% contro

140 tudy show no elevated risk for overall, high-grade or advanced-stage prostate cancer, or death due to

141 n a substantial proportion of pediatric high-grade gliomas (pHGG), often in association with TP53 los

142 ations of H3F3A in aggressive pediatric high-grade gliomas generate K27M or G34R/V mutant histone H3.

143 aluated multi-omics profiles of primary high-grade serous ovarian cancer tumours (N=357) to delineate

144 Primary and rare high-grade HCC developed in a genetic mouse model.

145 ict occurrence of residual or recurrent high-grade cervical intraepithelial neoplasia of grade two or

146 ients with platinum-sensitive, relapsed high-grade serous ovarian cancer.

147 de dissection, which disclosed residual high-grade muscle-invasive urothelial cancer extending to the

148 ars or older, had a platinum-sensitive, high-grade serous or endometrioid ovarian, primary peritoneal

149 m diffuse large B-cell lymphoma, termed high-grade B-cell lymphoma with translocations involving myc

150 In 90% of the high-grade TRAMP tumors, a mismatch in perfusion and metaboli

151 of low-grade fibrillary astrocytoma to high-grade anaplastic gliomas.

152 Barrett's esophagus for progression to high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC

153 factors associated with progression to high-grade dysplasia (HGD) or esophageal adenocarcinoma (EAC)

154 elodysplasia, whereas transformation to high-grade lymphoma occurred in 3 patients who had received c

155 to optimal field and transformation to high-grade radiation-associated sarcomas.

156 d cells, and prevention of low-grade to high-grade transition.

157 neoplasms, including germ cell tumors, high-grade and low-grade carcinomas and benign tissues.

158 modulation in earlier studies that used high-grade equipment in laboratory settings.

159 preselection of urothelial cells, where high-grade urothelial cancer cells are characterized by a lar

160 gene transfer vector, for patients with high-grade (HG) BCG-refractory or relapsed NMIBC.

161 omas, tubular adenomas >/=10 mm or with high-grade dysplasia, and conventional adenomas with villous

162 dysplastic cases and five patients with high-grade dysplasia.

163 radiology review for 133 patients with high-grade glioma.

164 lticenter trial involving patients with high-grade glioma.

165 vels of SLFN5 expression correlate with high-grade gliomas and shorter overall survival in patients s

166 als and Methods Seventeen patients with high-grade gliomas who had received 10-44 administrations of

167 nts, hyperammonemia was associated with high-grade HE and worse 21-day TFS.

168 Therefore, patients with high-grade invasive tumors should be monitored closely, espec

169 CA1 or BRCA2 mutations in patients with high-grade serous ovarian cancer (HGSC) are associated with f

170 gh) groups, especially in patients with high-grade serous ovarian cancer (HGSOC).

171 t an exceptional case of a patient with high-grade serous ovarian cancer, treated with multiple chemo

172 tudy included 90 comatose patients with high-grade spontaneous subarachnoid hemorrhage who underwent

173 ic murine models and is associated with high-grade tumors in patients.

174 num-based chemotherapy in patients with high-grade, recurrent, platinum-sensitive ovarian carcinoma.

175 ant negative correlation may indicate higher-grade elements within the tumor leading to poorer outcom

176 with a worse PFS, which may indicate higher-grade elements within the tumor.

177 require clinical translation and industrial-grade integration into routine workflow.

178 esent and carefully characterize an industry-grade CMOS camera as a cost-efficient alternative to com

179 ow-grade [well differentiated], intermediate-grade [moderately differentiated], and high-grade [poorl

180 (11 of 27); the sensitivity for intermediate-grade DCIS components was 84.1% (53 of 63) versus 34.9%

181 -grade DCIS and, less markedly, intermediate-grade DCIS decreased in subsequent rounds.

182 nsecutive patients with low- or intermediate-grade gastroenteropancreatic NETs took part in this pros

183 is versus NPZ, and (d) high- or intermediate-grade tumors versus low-grade tumors.

184 Low-grade gliomas with favorable characteristics are slow-gr

185 Low-grade heat energy from sources below 100 degrees C is av

186 Low-grade serous ovarian carcinomas (LGSC) are associated wi

187 Low-grade, chronic inflammation has been associated with man

188 s neoplasms (IPMN), 2 adenocarcinomas, 1 low-grade intraepithelial pancreatic neoplasia, and 1 case o

189 croRNA profiles, immunosenescence, and a low-grade chronic inflammation (inflammaging).

190 Osteoarthritis (OA) is a low-grade chronic inflammatory joint disease.

191 The overall evidence provides a low-grade level of the evidence supporting the efficacy of A

192 rt a detailed study of a musician with a low-grade tumor in the right temporal lobe.

193 cluding germ cell tumors, high-grade and low-grade carcinomas and benign tissues.

194 io to distinguish between high-grade and low-grade glial tumors.

195 Thus, microglia and low-grade inflammation of myelinated tracts emerged as the t

196 o to discriminate between high-grade and low-grade tumors to be 2.21.

197 bladder and renal carcinomas as well as low-grade gliomas.

198 this proportion increased through ASCUS, low-grade squamous intraepithelial lesions, CIN1, and CIN2 (

199 erson-years among patients with baseline low-grade dysplasia (95% CI 1.5-7.2), and 7.3 per 100 person

200 erson-years among patients with baseline low-grade dysplasia (95% CI, 4.9-14.0), and 13.5 per 100 per

201 sex, smoking, length of BE, and baseline low-grade dysplasia that identified patients with BE at low,

202 methodology for differentiating between low-grade and high-grade DCIS.

203 WHO III: 17, WHO IV: 13, without biopsy low-grade: 1, high-grade: 1) were investigated with a hybrid

204 ontrast enhancement of vertebral bodies, low-grade destruction of vertebral bodies, hyperintense/homo

205 that DACH1 was higher in normal breast, low-grade and luminal-type cancer in comparison with breast

206 ther TSPO imaging can accurately capture low-grade inflammatory processes such as those present in sc

207 which subtle myelin abnormalities cause low-grade neuroinflammation and catatonic behavior.

208 lenge the common assumption that central low-grade inflammation in schizophrenia is mirrored by incre

209 es are associated with increased chronic low-grade inflammation and elevated plasma glucose levels.

210 olic disorder are accompanied by chronic low-grade inflammation has fundamentally changed our view of

211 Obesity is associated with chronic low-grade inflammation of adipose tissue (AT) and an increas

212 glucose metabolism, satiety, and chronic low-grade inflammation to contribute to obesity and type 2 d

213 Chronic low-grade inflammation, a hallmark of obesity, involves immu

214 Obesity is associated with chronic low-grade inflammation, and metabolic regulators linking obe

215 atypical, metabolically induced, chronic low-grade inflammation, plays an important role in the devel

216 erized by insulin resistance and chronic low-grade inflammation.

217 gen species (ROS) production and chronic low-grade inflammation.

218 Obesity is characterized by chronic low-grade, systemic inflammation, altered gut microbiota, an

219 ent in exosome secretion have a chronic, low-grade inflammatory phenotype characterized by elevated i

220 ng, length of BE, and baseline-confirmed low-grade dysplasia were significantly associated with progr

221 rit (or ZT), which can directly converts low-grade wasted heat (400 to 500 K) into electricity, has b

222 h neurofibromatosis type 1 (NF1) develop low-grade brain tumors throughout the optic pathway.

223 dren with NF1 are at risk for developing low-grade gliomas of the optic pathway and brainstem, indivi

224 kurtosis imaging (DKI) to differentiate low-grade glioma (LGG) (World Health Organization [WHO] grad

225 ion, leading to microbiota encroachment, low-grade inflammation (LGI), and metabolic syndrome.

226 with inflammatory bowel disease and flat low-grade dysplasia (fLGD) in the colon.

227 as histologic grade (G1, G2, or G3, for low-grade [well differentiated], intermediate-grade [moderat

228 a new candidate susceptibility gene for low-grade and borderline serous EOC.

229 imaging versus conventional imaging for low-grade DCIS components was 74.0% (20 of 27) versus 40.7%

230 ents with T1N0 breast cancer was 10% for low-grade disease, 13% for moderate-grade disease, and 17% f

231 r, although it resulted in more frequent low-grade toxicities.

232 cale TOEC systems to extract energy from low-grade heat and identifies key factors for performance op

233 has the potential to harvest energy from low-grade heat sources by using a temperature difference to

234 rmocells) are of interest for harvesting low-grade waste thermal energy because of their potentially

235 mance for IDH gene mutation detection in low-grade glioma (AUC, 0.818) and MTI in high-grade glioma (

236 CMRO2 was decreased (P = .037) in low-grade glioma with a mutated IDH gene, and MTI was signif

237 with significantly inferior survival in low-grade glioma.

238 on is the earliest genetic alteration in low-grade gliomas (LGGs), but its role in tumor recurrence i

239 Prespecified outcome measures included low-grade CIN (grade 1 [CIN1]) and high-grade CIN (grade 2 [

240 e ovarian tumors (BOT) can progress into low-grade serous carcinomas and have relatively indolent cli

241 A condition more common than IBD is low-grade inflammation, which correlates with altered gut mi

242 hemotherapy in women with stage II to IV low-grade serous carcinoma of the ovary or peritoneum.

243 Conclusion Women with stage II to IV low-grade serous carcinoma who received HMT after primary tr

244 individuals with NF2 typically manifest low-grade tumors affecting the cranial nerves (vestibular sc

245 red it to non-transformed and neoplastic low-grade and high-grade prostate epithelial tissue from rad

246 syndrome are prone to the development of low-grade brain tumors (gliomas) within the optic pathway (o

247 ld be associated with the development of low-grade carcinomas.

248 unexpected genes; permitted detection of low-grade constitutional, somatic, and revertant mosaicism;

249 e prevalence round; conversely, rates of low-grade DCIS and, less markedly, intermediate-grade DCIS d

250 th Barrett's esophagus, the diagnosis of low-grade dysplasia (LGD) is subjective, and reported outcom

251 th the transformation and progression of low-grade fibrillary astrocytoma to high-grade anaplastic gl

252 cally nonsignificantly increased risk of low-grade serous tumors (pOR = 1.48, 95% CI: 0.92, 2.38) was

253 iogenic myeloid cells, and prevention of low-grade to high-grade transition.

254 y data seem to confirm their activity on low-grade NHL.

255 ) with residual or progressive benign or low-grade brain tumors at a single center between April 2001

256 th residual and/or progressive benign or low-grade brain tumors requiring radiotherapy for long-term

257 th residual and/or progressive benign or low-grade brain tumors treated with SCRT and ConvRT techniqu

258 of undetermined significance (ASC-US) or low-grade squamous intraepithelial lesions (LSIL) who were t

259 These pediatric low-grade gliomas (LGGs) are fundamentally different from ID

260 Pediatric low-grade gliomas (PLGGs) are commonly associated with BRAF

261 Results Low-grade (WHO grade II) glioma showed areas with increased

262 Results Low-grade tumors (grade 0, 1, or 2) demonstrated a favorable

263 ltrasound was judged semiquantitatively; low-grade contrast enhancement (CE) suggested its absence, a

264 se recurrence in women with early-stage, low-grade endometrial carcinoma.

265 dity in women with presumed early-stage, low-grade endometrial carcinoma?

266 ls in patients with active FPIES suggest low-grade intestinal mast cell activation or increased mast

267 school-aged children suggesting systemic low-grade inflammation as a phenotypic characteristic of thi

268 ch was strongly associated with systemic low-grade inflammation.

269 Recent findings suggest that low-grade inflammation in the intestine is promoted by consu

270 derlying cause of catatonic signs is the low-grade inflammation of white matter tracts, which marks a

271 histologic and molecular features of the low-grade lesions.

272 ed IL-6 production in this depot and the low-grade systemic inflammation typically associated with vi

273 and high-grade tumors from other tissue (low-grade tumors or benign tissue).

274 ease in intestinal permeability leads to low-grade inflammation.

275 Histologic analysis showed absent to low-grade inflammatory infiltrates without cardiomyocyte nec

276 tmosphere at ambient conditions by using low-grade heat from natural sunlight at a flux of less than

277 fy contaminated, acidic wastewater using low-grade heat sources, such as geothermal energy, without c

278 igh- or intermediate-grade tumors versus low-grade tumors.

279 Patients with untreated low-volume low-grade prostate cancer (clinical stage T2a or lower; Glea

280 ore favorable prognosis, and tumors with low-grade histology especially tend evolve slowly.

281 Obesity is associated with low-grade inflammation and elevated levels of circulating sa

282 and type 2 diabetes are associated with low-grade inflammation and specific changes in gut microbiot

283 ons observed during the development of lower-grade glioma (LGG).

284 ation profiles more closely resembling lower-grade tumors.

285 10% for low-grade disease, 13% for moderate-grade disease, and 17% for high-grade disease; the corre

286 apid vortex agitation (>/=3200 rpm) in LC/MS-grade solvents and by exposing them to the DART source j

287 453 bereaved ninth-grade students aged 13-17 years who had expressed intere

288 Nuclear-grade graphite is a critically important high-temperatur

289 meeting standards on reading and math end-of-grade examinations in third grade in 2006 to 2012.

290 the acceptable purity of 99.996% for polymer-grade C2 H4 ), as demonstrated by experimental breakthro

291 Early cortical infarcts are common in poor-grade patients after aneurysmal subarachnoid haemorrhage

292 ed solution for the analysis and publication-grade graphical presentation of dithionite scramblase as

293 sequencing, which will lead to the reference-grade assembly of allopolyploid cotton and serve as a ge

294 ne of seronegative individuals in a research-grade assay.

295 samples (n = 158) were tested with research-grade reagents and 122 independent validation set sample

296 Periodontal Indices, respectively, on sixth-grade school children (n = 1,539) of Medak District in T

297 improve power densities compared to standard-grade CEMs when performing RED using streams containing

298 A steep-graded association exists between decreasing number of c

299 edure, and categorized into one out of three-grades in the HOUSE classification system, and concomita

300 patient experienced a dose-limiting toxicity-grade 3 transient asymptomatic hyponatremia at the 1.0-m